Edwards lifesciences reports fourth quarter results

Irvine, calif.--(business wire)--edwards lifesciences (nyse: ew) today reported financial results for the quarter ended december 31, 2023. highlights and outlook q4 sales grew 14 percent to $1.53 billion; constant currency1 sales grew 13 percent q4 tavr sales grew 13 percent; constant currency sales grew 12 percent q4 eps of $0.61; adjusted1 eps of $0.64 2023 sales of $6.0 billion grew 12 percent; eps of $2.30; adjusted eps of $2.51 completed enrollment early in progress pivotal trial, studying.
EW Ratings Summary
EW Quant Ranking